Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis, Allergic, Seasonal | 4 | 2013 | 22 | 0.290 |
Why?
|
| Anti-Allergic Agents | 5 | 2008 | 27 | 0.250 |
Why?
|
| Histamine H1 Antagonists | 4 | 2005 | 22 | 0.240 |
Why?
|
| Asthma | 2 | 2006 | 345 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 511 | 0.180 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2008 | 43 | 0.180 |
Why?
|
| Double-Blind Method | 9 | 2013 | 1738 | 0.140 |
Why?
|
| Androstadienes | 2 | 2008 | 41 | 0.130 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 2 | 2006 | 2 | 0.130 |
Why?
|
| Terfenadine | 2 | 2004 | 4 | 0.120 |
Why?
|
| Beclomethasone | 1 | 2013 | 4 | 0.110 |
Why?
|
| Loratadine | 2 | 2003 | 4 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 234 | 0.100 |
Why?
|
| Child | 9 | 2013 | 6405 | 0.090 |
Why?
|
| Cetirizine | 1 | 2006 | 1 | 0.070 |
Why?
|
| Ephedrine | 1 | 2006 | 7 | 0.070 |
Why?
|
| Dibenzoxepins | 1 | 2005 | 1 | 0.070 |
Why?
|
| Adolescent | 6 | 2013 | 8912 | 0.060 |
Why?
|
| Administration, Intranasal | 3 | 2013 | 88 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2003 | 43 | 0.050 |
Why?
|
| Omalizumab | 1 | 2003 | 24 | 0.050 |
Why?
|
| Urticaria | 1 | 2003 | 84 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 151 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2002 | 47 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2006 | 2800 | 0.050 |
Why?
|
| Quality of Life | 3 | 2006 | 1515 | 0.050 |
Why?
|
| Male | 10 | 2013 | 37321 | 0.040 |
Why?
|
| Adult | 7 | 2013 | 21403 | 0.040 |
Why?
|
| Female | 10 | 2013 | 38074 | 0.040 |
Why?
|
| Aged | 5 | 2013 | 14862 | 0.040 |
Why?
|
| Middle Aged | 6 | 2013 | 21147 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1745 | 0.040 |
Why?
|
| Fluticasone | 2 | 2008 | 12 | 0.030 |
Why?
|
| Humans | 10 | 2013 | 68618 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2008 | 411 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2013 | 80 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 187 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2008 | 7029 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2006 | 14 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 123 | 0.020 |
Why?
|
| Olopatadine Hydrochloride | 1 | 2005 | 1 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2006 | 56 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2006 | 304 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2004 | 57 | 0.010 |
Why?
|
| Headache | 1 | 2004 | 68 | 0.010 |
Why?
|
| Safety | 1 | 2003 | 145 | 0.010 |
Why?
|
| Skin Tests | 1 | 2002 | 30 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2003 | 98 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 567 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 186 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3259 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 3187 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1330 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 931 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 4848 | 0.010 |
Why?
|